Company intelligence / Profile preview

GeneDx

Gaithersburg, Maryland, United Statesgenedx.com ↗

Ownership: Public · WGS
Development stage: Other

Overview

GeneDx has sequenced over three quarters of a million exomes/genomes. Their clinical results have demonstrated that exome/genome sequencing delivers higher diagnostic yield than traditional methods such as chromosomal microarray or multigene panels. Rapid whole genome sequencing can identify genetic causes in critically ill infants within as little as two days. The GUARDIAN study led by GeneDx has shown the value of genomic newborn screening at scale to detect actionable conditions missed by standard protocols.

Therapeutic areas: Rare DiseasesNeurologyMetabolic DisordersPsychiatryDermatologyOphthalmologyCardiovascular
Modalities: Diagnostic test (Exome sequencing)Diagnostic test (Genome sequencing)Diagnostic test (Oligonucleotide-based microarray)Diagnostic test (Deletion/duplication analysis)
Industry: Molecular Diagnostics

Partnerships

Collaborates with medical/scientific/patient advocacy communities

Financials

Market cap: $2.5B
Total revenue: $114.4M
Enterprise value: $2.5B

Beyond the preview

Go deeper on GeneDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneDx.

Explore the full profile